The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1344
August 9, 2010
View Complete Issue         Table of Contents 2019 
Armodafinil (Nuvigil) for Wakefulness
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Armodafinil (Nuvigil) for Wakefulness
August 9, 2010 (Issue: 1344)
Armodafinil (Nuvigil – Cephalon), the R-enantiomer of the non-amphetamine stimulant modafinil (Provigil – Cephalon; Alertec – Shire in Canada), is being promoted directly to the public for treatment of excessive daytime sleepiness associated...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Armodafinil (Nuvigil) for Wakefulness
Article code: 1344a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.